A single-institution experience with bevacizumab in the treatment of metastatic colorectal cancer and in conjunction with liver resection

por Osterlund, Pia, Peltonen, Reetta, Alanko, Tuomo, Bono, Petri, Isoniemi, Helena
Publicado 2014

High TKTL1 expression as a sign of poor prognosis in colorectal cancer with synchronous rather than metachronous liver metastases

por Peltonen, Reetta, Ahopelto, Kaisa, Hagström, Jaana, Böckelman, Camilla, Haglund, Caj, Isoniemi, Helena
Publicado 2020

Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases

por Peltonen, Reetta, Gramkow, Mathias H., Dehlendorff, Christian, Osterlund, Pia J., Johansen, Julia S., Isoniemi, Helena
Publicado 2020